Consistent with the aforementioned findings, a study conducted by Shimizu et al. [54] demonstrated that a high pre-treatment serum GLB/ALB ratio was an independent factor which predicted worse OS in HCC patients receiving curative surgical resection. This evidence concerns the gene ALB and hepatocellular carcinoma.